InvestorsHub Logo
Followers 0
Posts 37
Boards Moderated 0
Alias Born 01/15/2017

Re: None

Monday, 04/24/2017 5:47:14 PM

Monday, April 24, 2017 5:47:14 PM

Post# of 4817
Beckton Dickinson buys C. R. Bard for $24 billion and ATRS does not move. The market is really missing this one. Injection devices with strong IP are going to be increasingly in demand by Big Pharma. Further, pharma M & A is projected to increase in 2017 per linked article
http://bit.ly/2pdsISt ATRS is set to soar--when the market wakes up!